Which anticoagulant is safest for patients with morbid obesity?

Patients on warfarin or NOACs have a similar number of events, finds US study

Non-vitamin K oral anticoagulants (NOACs) and warfarin appear to be similarly safe in morbidly obese patients with atrial fibrillation (AF) and venous thromboembolism (VTE), according to new US findings.